Tirzepatide leads to greater weight loss than semaglutide among adults with obesity

1. In this randomized controlled trial, among adults with obesity, it was found that tirzepatide resulted in a significantly greater reduction in body weight and waist circumference than semaglutide. 2. Adverse events led to treatment discontinuation more often in the semaglutide group than in the tirzepatide group. Evidence Rating Level: 1 (Excellent) Study Rundown: There […]